Association of myocardial angiogenesis with structural and functional ventricular remodeling in aortic stenosis

Seung-Pyo Lee1, Hyung-Kwan Kim1, Yong-Jin Kim1

  • 1Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Insights

Myocardial angiogenesis increases with left ventricular (LV) hypertrophy in patients with aortic stenosis (AS) and normal ejection fraction (EF). This study investigated the link between blood vessel density and LV remodeling in AS patients.

Area of Science:

  • Cardiovascular Biology
  • Vascular Biology
  • Cardiac Pathophysiology

Background:

  • Myocardial angiogenesis, the formation of new blood vessels in the heart muscle, is crucial for cardiac health.
  • Reduced angiogenesis is linked to left ventricular (LV) systolic dysfunction in animal models of hypertrophy.
  • The relationship between angiogenesis and LV remodeling in human aortic stenosis (AS) patients with preserved ejection fraction (EF) remains under-investigated.

Purpose of the Study:

  • To investigate the relationship between myocardial angiogenesis and functional/structural LV remodeling parameters.
  • To analyze angiogenesis in patients with moderate to severe AS and normal LV ejection fraction (LVEF).

Main Methods:

  • 38 patients with moderate/severe AS and LVEF > 50% were included.
  • LV endomyocardial biopsies were obtained during aortic valve replacement.
  • Myocardial blood vessel density was assessed using CD31 staining.

Main Results:

  • Myocardial angiogenesis increased with worsening LV systolic function (LVEF), elevated LV filling pressure (E/e'), and progressive LV hypertrophy (LV mass index).
  • Angiogenesis correlated with the severity of aortic stenosis and differed significantly across LV geometry patterns.
  • LV mass index and LVEF were significant predictors of myocardial blood vessel density.

Conclusions:

  • A strong association exists between myocardial angiogenesis and LV remodeling in AS patients with normal LVEF.
  • Increased angiogenesis correlates with LV hypertrophy in this patient group.
  • Further research is needed to elucidate the underlying mechanisms.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
583